Skip to main content

Peer Review reports

From: Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Original Submission
2 May 2018 Submitted Original manuscript
4 Oct 2018 Author responded Author comments - Axel Heidenreich
7 Jul 2018 Reviewed Reviewer Report - Antonello Veccia
3 Aug 2018 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 2
4 Oct 2018 Submitted Manuscript version 2
13 Nov 2018 Author responded Author comments - Axel Heidenreich
12 Oct 2018 Reviewed Reviewer Report - Antonello Veccia
18 Oct 2018 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 3
13 Nov 2018 Submitted Manuscript version 3
6 Dec 2018 Author responded Author comments - Axel Heidenreich
Resubmission - Version 4
6 Dec 2018 Submitted Manuscript version 4
Publishing
10 Dec 2018 Editorially accepted
7 Jan 2019 Article published 10.1186/s12885-018-5203-y

You can find further information about peer review here.

Back to article page
\